Arca
Skip to content
Tools
Tools

-ast

Anti-allergy or anti-inflammatory drugs that work without blocking histamine.

  • Drugs ending in -ast: 36
  • Approved somewhere: 8
  • With a US drug page: 8

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-ast
Class
Anti-allergy or anti-inflammatory drugs that work without blocking histamine
Most common targets
Phosphodiesterase 4 (12), CYSLTR1 (3), ITGAL, ITGB2 (1), PDE3A (1), PDE10A (1), PDE5A (1), ITGA4, ITGB1 (1), ITGA4, ITGB7 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -ast or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
LifitegrastApprovedITGAL, ITGB2Integrin alpha-L/beta-2 (LFA-1) antagonist
PemirolastPhase 2—Unknown
IbudilastApprovedPhosphodiesterase 4, PDE3A, PDE10A, PDE5APhosphodiesterase 4 inhibitor
TranilastPhase 3——
AsengeprastPhase 2——
BexotegrastPhase 2——
FirategrastPhase 2ITGA4, ITGB1, ITGA4, ITGB7Integrin alpha-4/beta-1 antagonist
NesvategrastPhase 2——
OfirnoflastPhase 2——
UsnoflastPhase 2——
ValategrastPhase 2——
Fibroblast growth FACTOR-1Phase 1——
SelnoflastPhase 1——
Andolast—KCNMA1Calcium-activated potassium channel subunit alpha-1 activator
MontelukastApprovedCYSLTR1Cysteinyl leukotriene receptor 1 antagonist
ZafirlukastApprovedCYSLTR1Cysteinyl leukotriene receptor 1 antagonist
PranlukastApprovedCYSLTR1Cysteinyl leukotriene receptor 1 antagonist
GemilukastPhase 2——
TipelukastPhase 2——
ApremilastApprovedPhosphodiesterase 4Phosphodiesterase 4 inhibitor
RoflumilastApprovedPhosphodiesterase 4Phosphodiesterase 4 inhibitor
DifamilastPhase 3Phosphodiesterase 4Phosphodiesterase 4 inhibitor
NerandomilastPhase 2——
CilomilastPhase 3Phosphodiesterase 4Phosphodiesterase 4 inhibitor
MufemilastPhase 3——
TetomilastPhase 3Phosphodiesterase 4Phosphodiesterase 4 inhibitor
ZatolmilastPhase 3PDE4DPhosphodiesterase 4D inhibitor
DovramilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
LotamilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
OglemilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
OrismilastPhase 2——
RevamilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
TofimilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
TranimilastPhase 2Phosphodiesterase 4Phosphodiesterase 4 inhibitor
IdrebormilastPhase 1——
SeratrodastApprovedTBXA2RThromboxane A2 receptor antagonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.